The key factors driving the growth of genotyping market are technological advancements and the increasing prevalence of target diseases, such as cancer, diabetes, and Alzheimer's. The introduction of novel technologies that minimize errors considerably and yield efficient results are also estimated to enhance the penetration rates of these products.
The rising prevalence of genetic diseases, such as Parkinson's, turner syndrome, and Alzheimer's is the high impact rendering driver for the market growth. Genotyping facilitates rapid sequencing and the early diagnosis of these aforementioned diseases further aid healthcare professionals to decide on probable treatment options.
Request Exclusive Free PDF Sample Of This Report @ https://dataintelo.com/request-sample/?reportId=444
Companies are undertaking R&D initiatives for the development of advanced products to cater to the increasing demands of the target population. Genotyping tests and kits are available for the screening of potential biomarkers that can be used to assess a person's risk of developing a disease, or determine their carrier state.
Polymerase Chain Reaction (PCR) is the key technology used by healthcare professionals and researchers for accurate and rapid detection of genetic changes. The introduction of newer PCR technologies in conjunction with computer programs, such as reverse transcription PCR, inverse PCR, Quantitative PCR (Q-PCR), and assembly PCR is also expected to fuel the genotyping market growth.
Global Genotyping Market is expected to reach USD 37.1 billion by 2024.
The Genotyping Market is estimated to grow at a significant CAGR over the forecast period as the scope and its applications are rising enormously across the globe.Growing availability of several types of products, decreasing cost of DNA sequencing, rising awareness and occurrence of genetic diseases, increasing use of plant and animal livestock for genetic analysis, and growing demand for pharmacogenomics in drug discovery & development are documented as major factors of Genotyping Market that are estimated to enhance the growth in the years to come.
However, lack of trained personnel’s may restrain overall market growth in the coming years.
Instruments sector comprises of analyzers and sequencer & amplifiers.
Reagents and kits sector is estimated to grow at highest CAGR in the coming years.MALDI-TOF, Microarrays, Polymerase Chain Reaction (PCR), Capillary Electrophoresis, Sequencing, and other technologies may be explored in Genotyping in the forecast period.
Capillary Electrophoresis sector comprises Single Strand Conformation Polymorphism (SSCP), Restriction Fragment Length Polymorphism (RFLP), and Amplified Fragment Length Polymorphisms (AFLP).
According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.The growth of this market is mainly driven by technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595The reagents & kits segment is expected to grow at the highest CAGR during the forecast periodBased on product, the reagents and kits are expected to grow at the highest rate during the forecast period.
This segment is expected to witness the highest CAGR due to the easy accessibility of a wide range of reagents and the increasing need for genotyping in various applications.+ Based on product, the market is divided into reagents & kits, genotyping services, instruments, and bioinformatics.
The easy accessibility to a wide range of reagents and need for genotyping in various applications (such as assessing drug efficacy & safety, cutting down cost and time required for clinical development, personalizing the treatments for chronic diseases, and developing good breeds of animals and plants) have contributed to the high and repetitive consumption of reagents and kits as consumables in various genotyping applications.+ Based on technology, the genotyping assay market is segmented into PCR, microarrays, sequencing, capillary electrophoresis, MALDI-TOF, and other technologies.
The sequencing segment is expected to account for the largest share of the global genotyping market during the forecast period of 2018 to 2023.Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595Key Players and Strategies Adopted by Them:The genotyping market in the APAC is expected to grow at the highest CAGR during the forecast period.
This is due to the increasing incidence of chronic diseases, and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases and the spread of infectious and microbial diseases in APAC countries.
Global pharmaceutical and biopharmaceutical companies are also increasingly outsourcing clinical research and trials to companies in this region, which has increased the demand for genotyping products for drug profile assessment, drug efficacy and safety assessment, dosing determination, and drug response evaluation
